ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

31,025Medicare Part D Prescriptions Filled, Including Refills

Rank: 17 out of 6969

$1.68M Total Retail Price of All Prescriptions

Rank: 51 out of 6969

617 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
94% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

5% of this provider’s 617 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 29,654 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

35% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

50 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
SIMVASTATIN 1,275 1,184 1 1
LEVOTHYROXINE SODIUM 906 877 2 5
TRAMADOL HCL 829 797 3 27
OMEPRAZOLE 818 788 4 6
PRAVASTATIN SODIUM 771 734 5 19
DIOVAN HCT 754 727 6 57
TAMSULOSIN HCL 629 608 7 23
ALENDRONATE SODIUM 608 591 8 14
ATENOLOL 580 521 9 9
DIOVAN 567 556 10 26
ATORVASTATIN CALCIUM 527 493 11 11
AMLODIPINE BESYLATE 526 516 12 4
METOPROLOL TARTRATE 482 463 13 13
CITALOPRAM HBR 477 455 14 34
METFORMIN HCL 445 432 15 7
EVISTA 438 438 16 118
ZETIA 416 394 17 98
NEXIUM 407 384 18 52
MELOXICAM 405 375 19 36
LOSARTAN POTASSIUM 391 374 20 12
ALBUTEROL SULFATE 390 378 21 123
ZOLPIDEM TARTRATE 366 363 22 16
PANTOPRAZOLE SODIUM 362 332 23 31
FUROSEMIDE 359 347 24 10
SINGULAIR 357 349 25 84
CRESTOR 341 329 26 39
MIRTAZAPINE 330 330 27 76
CLONIDINE HCL 325 322 28 59
FINASTERIDE 324 311 29 80
GABAPENTIN 321 305 30 17
METOPROLOL SUCCINATE 313 303 31 22
LOSARTAN-HYDROCHLOROTHIAZIDE 311 299 32 53
PAROXETINE HCL 298 284 33 65
MECLIZINE HCL 293 288 34 100
SPIRONOLACTONE-HCTZ 291 284 35 296
DEXILANT 281 257 36 110
GLIMEPIRIDE 271 245 37 44
ALLOPURINOL 261 261 38 35
PLAVIX 261 250 38 68
RANITIDINE HCL 261 261 38 46
IBUPROFEN 254 250 41 29
TRAZODONE HCL 242 207 42 47
FAMOTIDINE 241 210 43 37
DONEPEZIL HCL 230 230 44 32
TRIAMCINOLONE ACETONIDE 221 209 45 55
ACTOS 214 214 46 61
CLOPIDOGREL 202 191 47 48
AZITHROMYCIN 199 186 48 42
CREON 194 171 49 147
LANSOPRAZOLE 189 187 50 171
SERTRALINE HCL 188 166 51 38
LIPITOR 185 180 52 89
VERAPAMIL ER 178 165 53 133
MONTELUKAST SODIUM 167 162 54 151
ADVAIR DISKUS 163 150 55 45
AMLODIPINE BESYLATE-BENAZEPRIL 162 141 56 91
SPIRONOLACTONE 161 160 57 102
LEVOFLOXACIN 158 153 58 109
DILTIAZEM 24HR CD 156 156 59 191
VYTORIN 151 150 60 148
CILOSTAZOL 148 145 61 208
BACLOFEN 148 142 61 86
ENALAPRIL MALEATE 147 135 63 56
PROAIR HFA 146 122 64 33
GLYBURIDE-METFORMIN HCL 144 135 R 65 92
DIGOXIN 144 144 65 71
NASONEX 141 131 67 144
HYDROXYZINE HCL 137 122 R 68 159
LISINOPRIL 135 134 69 2
AVODART 134 134 70 108
VENTOLIN HFA 132 132 71 125
LIDODERM 130 126 72 75
ESCITALOPRAM OXALATE 128 118 73 93
JANUVIA 128 124 73 41
GLIPIZIDE 127 127 75 21
ACIPHEX 124 121 76 181
FENOFIBRATE 118 111 77 63
ACTONEL 117 117 78 115
NATEGLINIDE 116 115 79 228
DICLOFENAC SODIUM 115 114 80 78
BENAZEPRIL HCL 114 114 81 18
POLYETHYLENE GLYCOL 3350 109 106 82 127
BENICAR 103 92 83 107
TRICOR 102 97 84 143
NORTRIPTYLINE HCL 102 102 84 140
FLUOXETINE HCL 99 95 86 43
PRIMIDONE 94 94 87 398
PROPRANOLOL HCL 92 92 88 153
NAMENDA 91 91 89 51
CYMBALTA 88 77 90 72
CARVEDILOL 87 87 91 25
LEXAPRO 87 81 91 200
RAMIPRIL 85 81 93 112
HYDROCHLOROTHIAZIDE 83 72 94 8
LOVAZA 82 59 95 77
VOLTAREN 81 81 96 105
FLUTICASONE PROPIONATE 80 79 97 24
CELEBREX 79 70 98 67
VALSARTAN-HYDROCHLOROTHIAZIDE 76 71 99 346
DOXAZOSIN MESYLATE 75 58 100 74
PIOGLITAZONE HCL 71 71 R 101 174
NIFEDIPINE ER 67 66 102 95
SYNTHROID 65 52 103 94
DIPHENOXYLATE-ATROPINE 65 59 103 214
PREDNISONE 64 63 105 70
CEPHALEXIN 64 55 105 96
DOXEPIN HCL 64 64 105 319
ISOSORBIDE MONONITRATE ER 63 57 108 81
MEGESTROL ACETATE 63 63 R 108 129
AMIODARONE HCL 63 63 108 184
DILTIAZEM 24HR ER 62 62 111 183
LEVOXYL 61 61 112 122
DETROL LA 56 56 113 223
OXYBUTYNIN CHLORIDE ER 55 55 114 165
WARFARIN SODIUM 53 53 115 20
SYMBICORT 53 53 115 149
POTASSIUM CHLORIDE 52 52 117 30
XOPENEX HFA 52 52 117 350
DILTIAZEM ER 52 52 117 206
SPIRIVA 52 52 117 66
PRAMIPEXOLE DIHYDROCHLORIDE 51 51 121 227
SEROQUEL 50 46 122 205
BONIVA 50 43 122 198
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.